ABSTRACT
Background Falls are the leading cause of injury-related mortality and hospitalization among adults aged ≥ 65 years. An important modifiable fall-risk factor is use of fall-risk increasing drugs (FRIDs). However, deprescribing is not always attempted or performed successfully. The ADFICE_IT trial evaluates the combined use of a clinical decision support system (CDSS) and a patient portal for optimizing the deprescribing of FRIDs in older fallers. The intervention aims to optimize and enhance shared decision making (SDM) and consequently prevent injurious falls and reduce healthcare-related costs.
Methods A multicenter, cluster-randomized controlled trial with process evaluation will be conducted among hospitals in the Netherlands. We aim to include 856 individuals aged ≥ 65 years that visit the falls clinic due to a fall. The intervention comprises the combined use of a CDSS and a patient portal. The CDSS provides guideline-based advice with regard to deprescribing and an individual fall-risk estimation, as calculated by an embedded prediction model. The patient portal provides educational information and a summary of the patient’s consultation. Hospitals in the control arm will provide care-as-usual. Fall-calendars will be used for measuring the time to first injurious fall (primary outcome) and secondary fall outcomes during one year. Other measurements will be conducted at baseline, 3, 6, and 12 months and include quality of life, cost-effectiveness, feasibility, and shared decision-making measures. Data will be analyzed according to the intention-to-treat principle. Difference in time to injurious fall between the intervention and control group will be analyzed using multilevel Cox regression.
Discussion The findings of this study will add valuable insights about how digital health informatics tools that target physicians and older adults can optimize deprescribing and support SDM. We expect the CDSS and patient portal to aid in deprescribing of FRIDs, resulting in a reduction in falls and related injuries.
Trial registration ClinicalTrials.gov NCT05449470 (7-7-2022)
Participant recruitment 7 July 2022-ongoing *
* Results of this study have not yet been published or submitted to any journal.
Protocol version 1
Trial sponsor Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT05449470
Funding Statement
The funders did not and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ADFICE_IT study protocol was reviewed and approved by the Medical Ethics review board of the Amsterdam University Medical Centres (METC AMC 2021_061).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data from the trial will be made available for other researchers after the study is completed for replication purposes and for original research questions. To obtain data, researchers will need to submit an analysis proposal, which will be evaluated by the ADFICE_IT Steering Group. More information regarding the data will be made available on our study website: http://www.onderzoeknaarvallen.nl (website information is also available in English).
Abbreviations
- ADFICE_IT
- Alerting on adverse Drug reactions: Falls prevention Improvement through developing a Computerized clinical support system: Effectiveness of Individualized medicaTion withdrawal
- CDSS
- Clinical decision support system
- CI
- confidence interval
- DCS
- Decisional Conflict Scale
- EQ-5D-5L
- EuroQol-5D-5L
- FRID
- Fall-Risk Increasing Drug
- IMCQ
- institute for Medical Technology Assessment Productivity Cost Questionnaire Medical Consumption Questionnaire
- IPCQ
- institute for Medical Technology Assessment Productivity Cost Questionnaire Productivity Cost Questionnaire
- MMSE
- Mini-Mental State Examination
- MOCA
- Montreal Cognitive Assessment
- MRC
- Medical Research Council
- NPIRQ
- Netherlands Patient Information Recall Questionnaire
- PrepDM
- Preparation for Decision-making scale
- QALY
- quality-adjusted life years
- QPL
- Question Prompt List
- RCT
- Randomized Controlled Trial
- SDM
- Shared Decision Making
- TAM
- Technology Acceptance Model
- TOPICS-SF
- The Older Persons and Informal Caregivers Survey – Short Form
- UI
- User Interface
- WSS
- Website Satisfaction Scale
